SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-024005
Filing Date
2018-09-07
Accepted
2018-09-07 16:45:39
Documents
1
Period of Report
2018-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7433
  Complete submission text file 0000899243-18-024005.txt   8835
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Issuer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CLOVIS ONCOLOGY, INC. 499 ILLINOIS STREET, SUITE 200 SAN FRANCISCO CA 94158
Business Address
Rolfe Lindsey (Reporting) CIK: 0001650504 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35347 | Film No.: 181060585